# Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

> **NCT03591133** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** TS-143
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03591133
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-24
- **Primary completion:** 2016-04-14
- **Final completion:** 2016-04-14
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03591133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03591133, "Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03591133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*